Skip to Main Content

Paper Details

Cell-free DNA measurable residual disease as a predictor of postallogeneic hematopoietic cell transplant outcomes.
Blood Adv
1
2023
BM, BM-derived DNA, Cell, Cell-free DNA, MRD, cfDNA, hematopoietic tissue, mutant allele, myeloid malignancies, patients, plasma, tumors, variant allele
Author NameAffiliation
Aparna PallavajjalaJohns Hopkins University School of Medicine
Christopher D GockeJohns Hopkins University School of Medicine
Christopher D GockeJohns Hopkins University School of Medicine
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
Richard J JonesSidney Kimmel Comprehensive Cancer Center, Johns Hopkins University
  • 1 - 5

Datasets

Release 1.2